© Copyright 2024 eOption, a division of Regal Securities, Inc., Member
FINRA/
SIPC |
Important Disclosures
950 Milwaukee Ave., Ste. 102 | Glenview, IL 60025
The information on this web site is for discussion and information purposes only. All accounts accepted at the discretion of eOption which accepts customer orders only on an unsolicited basis, and does not make any recommendations regarding any security or securities product with the possible exception of orders executed by our full service bond desk. Nothing contained herein should be considered as an offer to buy or sell any security or securities product. Online trading has inherent risks due to loss of online services or delays from system performance, risk parameters, market conditions, and erroneous or unavailable market data.
FINRA BrokerCheck reports for Regal Securities and its investment professionals are available at www.finra.org/brokercheck.
Options Disclosure: Options involve risk and are not suitable for all investors. Prior to trading options, you must be approved for options trading and read the Characteristics and Risks of Standardized Options. A copy may also be requested via email at support@eoption.com or via mail to eOption, 950 Milwaukee Ave., Ste. 102, Glenview, IL 60025. Online trading has inherent risks due to loss of online services or delays from system performance, risk parameters, market conditions, and erroneous or unavailable market data.
eOption Commissions: Broker-assisted orders are an additional $15. Option strategies involve multiple purchases; therefore your transaction costs may be significant for option strategy trades. A commission rate of $2.00 for equities and $3.99 + $.10/contract for options, per execution, applies to orders entered and filled by eOption's Auto Trade Desk and does not apply to customers who enter their trades directly into the eOption platform and are not utilizing the Auto Trade desk.
Broker Comparison: The competitor rates from published websites were verified on 05/25/2023 and are believed to be accurate, but not guaranteed. Commissions are subject to change without notice. At some firms, commissions may not reflect broker-assisted fees, orders over 1,000 shares, penny stock trades, OTCBB, pink sheet stocks or foreign stock orders. Firms may offer reduced commissions if additional criteria are met.
Blog & Commentary: eOption is neither affiliated with, sponsored by, nor endorses commentary and the opinions expressed are solely their own. Content is provided for educational and informational purposes only and eOption cannot attest to its accuracy or completeness. No information provided has been endorsed by eOption.com and does not constitute a recommendation by eOption to buy or sell a particular investment. You are solely responsible for your own investment decisions, and eOption makes no investment recommendations and does not provide financial, tax or legal advice.
Market Wants To Rally But the Headwinds Are Stiff – Use This Options Strategy
www.1option.com
Yesterday the S&P 500 gapped higher on more good vaccine news. Moderna’s vaccine is more effective than Pfizer’s and it is easier to transport. Stocks were able to hold the gains through most of the day and the S&P 500 closed above an important technical level. We can expect profit-taking if the market gets ahead of itself and this will not be a runaway rally. The gains we saw from the last five minutes of trading yesterday are being stripped away this morning with the futures down 20 points before the open.
There isn’t any incremental overnight news. Tesla is going to be added to the S&P 500 and that has tech stocks moving higher this morning.
Over the weekend a major Asia/Pacific trade deal was signed and it includes 1/3 of the world’s population and 1/3 of the world’s GDP.
The Coronavirus is spreading quickly and states are prepared for another shutdown. At least this time around we have more knowledge and the mortality rate has declined dramatically. Moderna’s new vaccine is 94.5% effective and it can be shipped at temperatures that are just above freezing. Pfizer’s drug has to be kept at -70C and that complicates distribution. Investors are looking past this rough patch and they are willing to stick with stocks knowing that the vaccines will get our economy back on track in Q1.
Politicians are not too concerned about a stimulus bill. No progress has been made since the election and it is likely to get lumped in with the budget. We are only a few weeks away from hitting the debt ceiling and this could be a giant package that gets negotiated at the last second.
Fortunately, our economy is not crashing. The numbers have been solid and that is giving politicians some breathing room. Small businesses and furloughed workers need this lifeline and hopefully it will not be delayed much longer.
Retailers will be posting earnings this week and we can expect a mixed bag. Companies with a strong online presence will do well and brick-and-mortar apparel will suffer. Stock valuations for the S&P 500 are rich at a P/E of 40.
Swing traders should stick with selling out of the money bullish put spreads. Yesterday’s rally did not impress me enough to buy SPY this morning. I am neutral to slightly bullish and I want to see us get through the all-time high with ease before I buy. Last week we were able to enter five new trades and I posted a new video yesterday with a nice swing trade. I want to see relative strength, heavy volume and a technical breakout through resistance. Option Stalker helps us find the stocks and I like selling bullish put spreads that expire in less than three weeks and that are below technical support. All of these factors greatly increase our probability of success and accelerated time decay is constantly working in our favor.
Content is provided by OneOption, LLC, which has no affiliation with Regal Securities, Inc. (“Regal”) This commentary is provided for information purposes only, and is not a recommendation, offer or solicitation by Regal to buy or sell securities or to adopt any investment strategy. Regal has not participated in the creation of the OneOption content and does not directly or indirectly endorse the content. Any reliance on this material is at the sole discretion of the reader.